Sigrid Nikol

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.

Sigrid Nikol, Jeffrey M. Isner, J. Geoffrey Pickering et al. · Journal of Clinical Investigation · 1992 · 380 citations · Full text

Angiogenesis, Medicine, Vascular Adaptation +13

Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update)

Robert J. Hinchliffe, Rachael O. Forsythe, Jan Apelqvist et al. · Diabetes/Metabolism Research and Reviews · 2020 · 351 citations · Full text

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

J. J. F. Belch, William R. Hiatt, Iris Baumgärtner et al. · The Lancet · 2011 · 334 citations · Full text

Regenerative Medicine, Thrombosis, Translational Medicine +8